Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis

被引:137
作者
Huang, MT
Ma, W
Yen, P
Xie, JG
Han, JK
Frenkel, K
Grunberger, D
Conney, AH
机构
[1] NYU, MED CTR, DEPT ENVIRONM MED, NEW YORK, NY 10016 USA
[2] COLUMBIA UNIV COLL PHYS & SURG, INST CANC RES, NEW YORK, NY 10032 USA
关键词
D O I
10.1093/carcin/18.1.83
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effects of topical applications of very low doses of curcumin (the major yellow pigment in turmeric and the Indian food curry) on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced oxidation of DNA bases in the epidermis and on tumor promotion in mouse skin were investigated, CD-1 mice were treated topically with 200 mnol of 7,12-dimethylbenz[a]anthracene followed one week later by 5 nmol of TPA alone or together with 1, 10, 100 or 3000 mmol of curcumin twice a week for 20 weeks. Curcumin-mediated effects on TPA-induced formation of the oxidized DNA base 5-hydroxymethyl-2'-deoxyuridine (HMdU) and tumor formation were determined. All dose levels of curcumin inhibited the mean values of TPA-induced HMdU formation in epidermal DNA (62-77% inhibition), but only the two highest doses of curcumin strongly inhibited TPA-induced tumor promotion (62-79% inhibition of tumors per mouse and tumor volume per mouse), In a second experiment, topical application of 20 or 100 mnol (but not 10 mmol) of curcumin together with 5 mmol TPA twice a week for 18 weeks markedly inhibited TPA-induced tumor promotion, Curcumin had a strong inhibitory effect on DNA and RNA synthesis (IC50 = 0.5-1 mu M) in cultured HeLa cells, but there was little or no effect on protein synthesis.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 48 条
[41]   ANTIOXIDANT ACTIVITY OF CURCUMIN AND RELATED COMPOUNDS [J].
SHARMA, OP .
BIOCHEMICAL PHARMACOLOGY, 1976, 25 (15) :1811-1812
[42]   PHARMACOLOGY OF DIFERULOYL METHANE (CURCUMIN), A NONSTEROIDAL ANTIINFLAMMATORY AGENT [J].
SRIMAL, RC ;
DHAWAN, BN .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (06) :447-452
[43]  
TANAKA T, 1994, CANCER RES, V54, P4653
[44]  
TODA S, 1985, CHEM PHARM BULL, V33, P1725
[45]  
TONNESEN HH, 1992, ACS SYM SER, V506, P143
[46]   ARACHIDONATE 5-LIPOXYGENASE INHIBITORS SHOW POTENT ANTIPROLIFERATIVE EFFECTS ON HUMAN-LEUKEMIA CELL-LINES [J].
TSUKADA, T ;
NAKASHIMA, K ;
SHIRAKAWA, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 140 (03) :832-836
[47]   RELATIONSHIP OF OXIDATIVE EVENTS AND DNA OXIDATION IN SENCAR MICE TO INVIVO PROMOTING ACTIVITY OF PHORBOL ESTER-TYPE TUMOR PROMOTERS [J].
WEI, HC ;
FRENKEL, K .
CARCINOGENESIS, 1993, 14 (06) :1195-1201
[48]  
WEI HC, 1991, CANCER RES, V51, P4443